| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/02/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 350k | $0.99 | $346.5k | | 08/02/2022 |
| 06/22/2022 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $2.01 | $20.4k | | 06/22/2022 |
| 11/10/2021 | Calithera Biosciences, Inc. | CALA | Purchase | Common Stock | 200k | $0.86 | $171.9k | | 11/10/2021 |
| 06/11/2021 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 20k | $2.28 | $45.6k | | 06/11/2021 |
| 06/04/2021 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 10k | $9.61 | $96.1k | | 06/03/2021 |
| 06/03/2021 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 40k | $9.48 | $379.3k | | 06/03/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $22.50 | $228.8k | | 05/04/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $0.00 | $0 | | 05/04/2021 |
| 08/10/2020 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 420k | $12.00 | $5M | | 08/10/2020 |
| 06/09/2020 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 20k | $5.25 | $105k | | 06/09/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $20.59 | $209.3k | | 05/28/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 2.9k | $20.59 | $59.3k | | 05/28/2020 |
| 12/20/2019 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 119k | $8.40 | $1000k | | 11/12/2019 |
| 11/12/2019 | Neoleukin Therapeutics, Inc. | AQXP | Conversion | Series A Preferred Stock | 12.6k | $0.00 | $0 | | 11/12/2019 |
| 11/12/2019 | Neoleukin Therapeutics, Inc. | AQXP | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 11/12/2019 |
| 09/11/2019 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 136.4k | $3.30 | $449.9k | | 09/09/2019 |
| 09/10/2019 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 36.7k | $3.08 | $113.3k | | 09/09/2019 |
| 09/09/2019 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 76.8k | $2.85 | $218.6k | | 09/09/2019 |
| 08/31/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 1.6M | $2.80 | $4.6M | | 08/31/2019 |
| 08/08/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | | 568k | $0.00 | $0 | | 08/08/2019 |
| 08/08/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | | 12.6k | $0.00 | $0 | | 08/08/2019 |
| 08/08/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Common Stock | 334.4k | $0.00 | $0 | | 08/08/2019 |
| 08/08/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | | 7.4k | $0.00 | $0 | | 08/08/2019 |
| 06/03/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $11.84 | $120.4k | | 06/03/2019 |
| 05/30/2019 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 11k | $5.42 | $59.6k | | 05/30/2019 |
| 02/07/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 4.3k | $14.00 | $59.7k | | 02/07/2019 |
| 05/31/2018 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 11k | $5.15 | $56.6k | | 05/31/2018 |
| 03/20/2018 | Seagen Inc. | SGEN | Grant | Non-qualified Stock Option (Right to buy) | 10.5k | $34.20 | $360k | | 03/20/2018 |
| 03/20/2018 | Seagen Inc. | SGEN | Exercise | Non-Qualified Stock Option (right to buy) | 7k | $10.61 | $74.3k | | 03/20/2018 |
| 03/20/2018 | Seagen Inc. | SGEN | Exercise | Non-Qualified Stock Option (right to buy) | 13.7k | $12.00 | $164.9k | | 03/20/2018 |
| 03/20/2018 | Seagen Inc. | SGEN | Exercise | Incentive Stock Option (right to buy) | 6.5k | $15.46 | $100k | | 03/20/2018 |
| 03/20/2018 | Seagen Inc. | SGEN | Exercise | Incentive Stock Option (right to buy) | 3.8k | $26.10 | $100k | | 03/20/2018 |
| 03/05/2018 | Seagen Inc. | SGEN | Sale | Common Stock | 7.2k | $52.70 | $379.4k | | 03/05/2018 |
| 03/05/2018 | Seagen Inc. | SGEN | Sale | Common Stock | 3.3k | $53.12 | $173k | | 03/05/2018 |
| 03/05/2018 | Seagen Inc. | SGEN | Exercise | Non-Qualified Stock Option (right to buy) | 7.2k | $8.96 | $64.5k | | 03/05/2018 |
|